APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanobody Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nanobody Discovery Service Market Outlook and Growth Opportunities 2026

4 March 2026193 pages

Choose your research edition.

Industry ResearchNanobody Discovery Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanobody Discovery Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Nanobody Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanobody Discovery Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanobody Discovery Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nanobody Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nanobody Discovery Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nanobody Discovery Service market include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nanobody Discovery Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nanobody Discovery Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nanobody Discovery Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nanobody Discovery Service market.

Nanobody Discovery Service Segment by Company

Creative Biolabs

Curia

Sanofi

NanoTag Biotechnologies

Shanghai Medicilon Inc.

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Yeasen Biotechnology（Shanghai）Co.,Ltd.

Fortis Life Sciences

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Biointron Biological Inc.

SAFE Pharmaceutical Technology Co., Ltd.

Abterra Biosciences

Chengdu Apak Biotechnology Co., Ltd.

ICarTab Biomedical Co., Ltd.

Wuhan Daian Biotech Ltd

Nanobody Discovery Service Segment by Type

Screening and Development Services

Engineering and Optimization Services

Production and Expression Services

Other Services

Nanobody Discovery Service Segment by Application

Drug Discovery

Biological Engineering

Clinical Diagnosis

Immune Research

Others

Nanobody Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nanobody Discovery Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nanobody Discovery Service key companies, revenue, market share, and recent developments.

3. To split the Nanobody Discovery Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nanobody Discovery Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nanobody Discovery Service significant trends, drivers, influence factors in global and regions.

6. To analyze Nanobody Discovery Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanobody Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanobody Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanobody Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanobody Discovery Service industry.

Chapter 3: Detailed analysis of Nanobody Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nanobody Discovery Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nanobody Discovery Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nanobody Discovery Service Industry Trends Table 2. Nanobody Discovery Service Industry Drivers Table 3. Nanobody Discovery Service Industry Opportunities and Challenges Table 4. Nanobody Discovery Service Industry Restraints Table 5. Global Nanobody Discovery Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nanobody Discovery Service Revenue Share by Company (2021-2026) Table 7. Global Nanobody Discovery Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nanobody Discovery Service Key Company Manufacturing Base & Headquarters Table 9. Global Nanobody Discovery Service Company, Product Type & Application Table 10. Global Nanobody Discovery Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nanobody Discovery Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Screening and Development Services Table 15. Significant Companies of Engineering and Optimization Services Table 16. Significant Companies of Production and Expression Services Table 17. Significant Companies of Other Services Table 18. Global Nanobody Discovery Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Nanobody Discovery Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Nanobody Discovery Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Nanobody Discovery Service Sales Value Share by Type (2021-2026) Table 22. Global Nanobody Discovery Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Drug Discovery Table 24. Significant Companies of Biological Engineering Table 25. Significant Companies of Clinical Diagnosis Table 26. Significant Companies of Immune Research Table 27. Significant Companies of Others Table 28. Global Nanobody Discovery Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Nanobody Discovery Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Nanobody Discovery Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Nanobody Discovery Service Sales Value Share by Application (2021-2026) Table 32. Global Nanobody Discovery Service Sales Value Share by Application (2027-2032) Table 33. Global Nanobody Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Nanobody Discovery Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Nanobody Discovery Service Sales Value Share by Region (2021-2026) Table 36. Global Nanobody Discovery Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Nanobody Discovery Service Sales Value Share by Region (2027-2032) Table 38. Global Nanobody Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nanobody Discovery Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Nanobody Discovery Service Sales Value Market Share by Country (2021-2026) Table 41. Global Nanobody Discovery Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Nanobody Discovery Service Sales Value Market Share by Country (2027-2032) Table 43. Creative Biolabs Company Information Table 44. Creative Biolabs Business Overview Table 45. Creative Biolabs Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Creative Biolabs Nanobody Discovery Service Product Portfolio Table 47. Creative Biolabs Recent Development Table 48. Curia Company Information Table 49. Curia Business Overview Table 50. Curia Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Curia Nanobody Discovery Service Product Portfolio Table 52. Curia Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sanofi Nanobody Discovery Service Product Portfolio Table 57. Sanofi Recent Development Table 58. NanoTag Biotechnologies Company Information Table 59. NanoTag Biotechnologies Business Overview Table 60. NanoTag Biotechnologies Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio Table 62. NanoTag Biotechnologies Recent Development Table 63. Shanghai Medicilon Inc. Company Information Table 64. Shanghai Medicilon Inc. Business Overview Table 65. Shanghai Medicilon Inc. Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio Table 67. Shanghai Medicilon Inc. Recent Development Table 68. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 69. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 70. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 72. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 73. Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information Table 74. Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview Table 75. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio Table 77. Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Development Table 78. Fortis Life Sciences Company Information Table 79. Fortis Life Sciences Business Overview Table 80. Fortis Life Sciences Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fortis Life Sciences Nanobody Discovery Service Product Portfolio Table 82. Fortis Life Sciences Recent Development Table 83. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 84. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 85. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 87. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 88. Biointron Biological Inc. Company Information Table 89. Biointron Biological Inc. Business Overview Table 90. Biointron Biological Inc. Nanobody Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Biointron Biological Inc. Nanobody Discovery Service Product Portfolio Table 92. Biointron Biological Inc. Recent Development Table 93. SAFE Pharmaceutical Technology Co., Ltd. Company Information Table 94. SAFE Pharmaceutical Technology Co., Ltd. Business Overview Table 95. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 97. SAFE Pharmaceutical Technology Co., Ltd. Recent Development Table 98. Abterra Biosciences Company Information Table 99. Abterra Biosciences Business Overview Table 100. Abterra Biosciences Nanobody Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Abterra Biosciences Nanobody Discovery Service Product Portfolio Table 102. Abterra Biosciences Recent Development Table 103. Chengdu Apak Biotechnology Co., Ltd. Company Information Table 104. Chengdu Apak Biotechnology Co., Ltd. Business Overview Table 105. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 107. Chengdu Apak Biotechnology Co., Ltd. Recent Development Table 108. ICarTab Biomedical Co., Ltd. Company Information Table 109. ICarTab Biomedical Co., Ltd. Business Overview Table 110. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio Table 112. ICarTab Biomedical Co., Ltd. Recent Development Table 113. Wuhan Daian Biotech Ltd Company Information Table 114. Wuhan Daian Biotech Ltd Business Overview Table 115. Wuhan Daian Biotech Ltd Nanobody Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio Table 117. Wuhan Daian Biotech Ltd Recent Development Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Nanobody Discovery Service Product Image Figure 2. Global Nanobody Discovery Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanobody Discovery Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Nanobody Discovery Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Screening and Development Services Image Figure 8. Engineering and Optimization Services Image Figure 9. Production and Expression Services Image Figure 10. Other Services Image Figure 11. Global Nanobody Discovery Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Nanobody Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Nanobody Discovery Service Sales Value Share by Type (2021-2032) Figure 14. Drug Discovery Image Figure 15. Biological Engineering Image Figure 16. Clinical Diagnosis Image Figure 17. Immune Research Image Figure 18. Others Image Figure 19. Global Nanobody Discovery Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Nanobody Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Nanobody Discovery Service Sales Value Share by Application (2021-2032) Figure 22. Global Nanobody Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Nanobody Discovery Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Nanobody Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Nanobody Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Nanobody Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Nanobody Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Nanobody Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Nanobody Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Nanobody Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Nanobody Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Nanobody Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Nanobody Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Nanobody Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Screening and Development Services
  • Engineering and Optimization Services
  • Production and Expression Services
  • Other Services
Applications
  • Drug Discovery
  • Biological Engineering
  • Clinical Diagnosis
  • Immune Research
  • Others
Companies covered
  • Creative Biolabs
  • Curia
  • Sanofi
  • NanoTag Biotechnologies
  • Shanghai Medicilon Inc.
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Yeasen Biotechnology（Shanghai）Co.,Ltd.
  • Fortis Life Sciences
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Biointron Biological Inc.
  • SAFE Pharmaceutical Technology Co., Ltd.
  • Abterra Biosciences
  • Chengdu Apak Biotechnology Co., Ltd.
  • ICarTab Biomedical Co., Ltd.
  • Wuhan Daian Biotech Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nanobody Discovery Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nanobody Discovery Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nanobody Discovery Service Market Dynamics
  1. 2.1 Nanobody Discovery Service Industry Trends
  2. 2.2 Nanobody Discovery Service Industry Drivers
  3. 2.3 Nanobody Discovery Service Industry Opportunities and Challenges
  4. 2.4 Nanobody Discovery Service Industry Restraints
3 Nanobody Discovery Service Market by Company
  1. 3.1 Global Nanobody Discovery Service Company Revenue Ranking in 2025
  2. 3.2 Global Nanobody Discovery Service Revenue by Company (2021-2026)
  3. 3.3 Global Nanobody Discovery Service Company Ranking (2024-2026)
  4. 3.4 Global Nanobody Discovery Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Nanobody Discovery Service Company Product Type and Application
  6. 3.6 Global Nanobody Discovery Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nanobody Discovery Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nanobody Discovery Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nanobody Discovery Service Market by Type
  1. 4.1 Nanobody Discovery Service Type Introduction
  2. 4.1.1 Screening and Development Services
  3. 4.1.2 Engineering and Optimization Services
  4. 4.1.3 Production and Expression Services
  5. 4.1.4 Other Services
  6. 4.2 Global Nanobody Discovery Service Sales Value by Type
  7. 4.2.1 Global Nanobody Discovery Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nanobody Discovery Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Nanobody Discovery Service Sales Value Share by Type (2021-2032)
5 Nanobody Discovery Service Market by Application
  1. 5.1 Nanobody Discovery Service Application Introduction
  2. 5.1.1 Drug Discovery
  3. 5.1.2 Biological Engineering
  4. 5.1.3 Clinical Diagnosis
  5. 5.1.4 Immune Research
  6. 5.1.5 Others
  7. 5.2 Global Nanobody Discovery Service Sales Value by Application
  8. 5.2.1 Global Nanobody Discovery Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nanobody Discovery Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Nanobody Discovery Service Sales Value Share by Application (2021-2032)
6 Nanobody Discovery Service Regional Value Analysis
  1. 6.1 Global Nanobody Discovery Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nanobody Discovery Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nanobody Discovery Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nanobody Discovery Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nanobody Discovery Service Sales Value (2021-2032)
  7. 6.3.2 North America Nanobody Discovery Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nanobody Discovery Service Sales Value (2021-2032)
  10. 6.4.2 Europe Nanobody Discovery Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nanobody Discovery Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nanobody Discovery Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nanobody Discovery Service Sales Value (2021-2032)
  16. 6.6.2 South America Nanobody Discovery Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nanobody Discovery Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nanobody Discovery Service Sales Value Share by Country, 2025 VS 2032
7 Nanobody Discovery Service Country-level Value Analysis
  1. 7.1 Global Nanobody Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nanobody Discovery Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nanobody Discovery Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nanobody Discovery Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nanobody Discovery Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nanobody Discovery Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nanobody Discovery Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Creative Biolabs
  2. 8.1.1 Creative Biolabs Company Information
  3. 8.1.2 Creative Biolabs Business Overview
  4. 8.1.3 Creative Biolabs Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Creative Biolabs Nanobody Discovery Service Product Portfolio
  6. 8.1.5 Creative Biolabs Recent Developments
  7. 8.2 Curia
  8. 8.2.1 Curia Company Information
  9. 8.2.2 Curia Business Overview
  10. 8.2.3 Curia Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Curia Nanobody Discovery Service Product Portfolio
  12. 8.2.5 Curia Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Nanobody Discovery Service Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 NanoTag Biotechnologies
  20. 8.4.1 NanoTag Biotechnologies Company Information
  21. 8.4.2 NanoTag Biotechnologies Business Overview
  22. 8.4.3 NanoTag Biotechnologies Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio
  24. 8.4.5 NanoTag Biotechnologies Recent Developments
  25. 8.5 Shanghai Medicilon Inc.
  26. 8.5.1 Shanghai Medicilon Inc. Company Information
  27. 8.5.2 Shanghai Medicilon Inc. Business Overview
  28. 8.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio
  30. 8.5.5 Shanghai Medicilon Inc. Recent Developments
  31. 8.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  32. 8.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  33. 8.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  34. 8.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  36. 8.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  37. 8.7 Yeasen Biotechnology（Shanghai）Co.,Ltd.
  38. 8.7.1 Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information
  39. 8.7.2 Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview
  40. 8.7.3 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio
  42. 8.7.5 Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Developments
  43. 8.8 Fortis Life Sciences
  44. 8.8.1 Fortis Life Sciences Company Information
  45. 8.8.2 Fortis Life Sciences Business Overview
  46. 8.8.3 Fortis Life Sciences Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fortis Life Sciences Nanobody Discovery Service Product Portfolio
  48. 8.8.5 Fortis Life Sciences Recent Developments
  49. 8.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  50. 8.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  51. 8.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  52. 8.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  54. 8.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  55. 8.10 Biointron Biological Inc.
  56. 8.10.1 Biointron Biological Inc. Company Information
  57. 8.10.2 Biointron Biological Inc. Business Overview
  58. 8.10.3 Biointron Biological Inc. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biointron Biological Inc. Nanobody Discovery Service Product Portfolio
  60. 8.10.5 Biointron Biological Inc. Recent Developments
  61. 8.11 SAFE Pharmaceutical Technology Co., Ltd.
  62. 8.11.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
  63. 8.11.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
  64. 8.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio
  66. 8.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
  67. 8.12 Abterra Biosciences
  68. 8.12.1 Abterra Biosciences Company Information
  69. 8.12.2 Abterra Biosciences Business Overview
  70. 8.12.3 Abterra Biosciences Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abterra Biosciences Nanobody Discovery Service Product Portfolio
  72. 8.12.5 Abterra Biosciences Recent Developments
  73. 8.13 Chengdu Apak Biotechnology Co., Ltd.
  74. 8.13.1 Chengdu Apak Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Chengdu Apak Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio
  78. 8.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments
  79. 8.14 ICarTab Biomedical Co., Ltd.
  80. 8.14.1 ICarTab Biomedical Co., Ltd. Company Information
  81. 8.14.2 ICarTab Biomedical Co., Ltd. Business Overview
  82. 8.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio
  84. 8.14.5 ICarTab Biomedical Co., Ltd. Recent Developments
  85. 8.15 Wuhan Daian Biotech Ltd
  86. 8.15.1 Wuhan Daian Biotech Ltd Company Information
  87. 8.15.2 Wuhan Daian Biotech Ltd Business Overview
  88. 8.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio
  90. 8.15.5 Wuhan Daian Biotech Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst